Bitcoin
73320.79
-995.19
-1.36%
Crude Oil
89.1
+0.42
+0.47%
Gold
4531.8
+83.4
+1.84%
Copper
6.42
+0.08
+1.32%
Silver
75.9
+1.01
+1.32%
Dow Jones
50644.28
+182.59
+0.36%
SP500
7564.09
+43.73
+0.58%
NASDAQ
26674.73
+18.55
+0.07%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
28.58
+99.00%
Top Gainers
1,630,860
Top Gainers
26.905
+74.47%
Top Gainers
2,240,106
Top Gainers
1.11
+64.86%
Top Gainers
2,296,091
Top Gainers
12.27
+64.22%
Top Gainers
1,345,642
Top Gainers
29.945
+55.72%
Top Gainers
11,416,285
Top Gainers
966
+50.00%
Top Gainers
179,059
Top Gainers
3.78
+43.12%
Top Gainers
192,000
Top Gainers
1.7
+32.94%
Top Gainers
273,423
Top Gainers
240.56
+27.14%
Top Gainers
7,164,396
Top Gainers
12
+25.08%
Top Gainers
197,885
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
2280
-1620.58%
Top Loosers
476,900
Top Loosers
589
-1100.48%
Top Loosers
880,254
Top Loosers
53.98
-99.89%
Top Loosers
517,322
Top Loosers
28.38872
-89.48%
Top Loosers
534,400
Top Loosers
28.36
-81.59%
Top Loosers
1,695,819
Top Loosers
82700
-81.02%
Top Loosers
763,022
Top Loosers
34.485
-55.17%
Top Loosers
592,801
Top Loosers
2.16
-50.46%
Top Loosers
25,108,332
Top Loosers
1686
-29.60%
Top Loosers
180,278
Top Loosers
5.5
-29.27%
Top Loosers
604,695
Top Loosers

In Today's Headlines

Palantir Is Down 20% in 2026 and It's Still My Favorite Stock Idea: Here's Why
03:38
28 May 2026
Palantir Is Down 20% in 2026 and It's Still My Favorite Stock Idea: Here's Why

The buy button keeps calling, and the data backs it up. Palantir (NASDAQ:PLTR | PLTR Price Prediction) stock is down 20% year to date in 2026 as of May 28, buy my conviction has only strengthened amid the drawdown.

B&W DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Babcock & Wilcox Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BW
03:36
28 May 2026
B&W DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Babcock & Wilcox Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BW

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Babcock & Wilcox Enterprises, Inc. (“B&W”) (NYSE: BW) between November 5, 2025 and March 11, 2026, inclusive (the “Class Period”), of the important June 15, 2026 lead plaintiff deadline.

GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript
03:34
28 May 2026
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript

GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript

MEDPACE DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP
03:34
28 May 2026
MEDPACE DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP

New York, New York--(Newsfile Corp. - May 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline. SO WHAT: If you purchased Medpace common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ALDEYRA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 29 Deadline in Securities Class Action First Filed by the Firm - ALDX
03:33
28 May 2026
ALDEYRA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 29 Deadline in Securities Class Action First Filed by the Firm - ALDX

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the “Class Period”), of the important May 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach
03:32
28 May 2026
Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach

Ionis Pharmaceuticals remains a Buy, with a compelling bull case despite a >125% 12-month share price increase. IONS is transitioning from niche indications to multi-billion-dollar markets, leveraging key partnerships and upcoming product launches. Projected 2030 revenues exceed $5bn, driven by Tryngolza, Dawnzera, and significant royalty streams from eplontersen, bepiroversen, and pelacarsen.

Global Battery Materials Appoints Former Samsung Executive Dr. Yi Hyon Paik as Technical Advisor
03:32
28 May 2026
Global Battery Materials Appoints Former Samsung Executive Dr. Yi Hyon Paik as Technical Advisor

Dr. Paik brings more than 30 years of battery, electronic materials, and energy storage leadership to the Global Battery Materials Technical Advisory Board. TORONTO, May 28, 2026 /PRNewswire/ -- Global Battery Materials Corp. ("GBM" or "the Company"), a vertically integrated critical minerals and technology company delivering natural graphite products and advanced anode materials, today announced the appointment of Dr. Yi Hyon Paik to its technical advisory board.

PVH Corp. to Report Q1 Earnings: What Surprise Awaits Investors?
03:31
28 May 2026
PVH Corp. to Report Q1 Earnings: What Surprise Awaits Investors?

PVH eyes Q1 FY26 revenues up 0.7% to $2B, but EPS is expected to drop about 22% as tariffs and uneven demand weigh on margins.

Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:31
28 May 2026
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, May 28, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit.

Procter & Gamble: A Solid 'Buy' With Some Caveats
03:29
28 May 2026
Procter & Gamble: A Solid 'Buy' With Some Caveats

Procter & Gamble's underperformance over the past year or so has made the stock increasingly attractive for long-term investors. A dividend yield of almost 3% might not sound exciting, but there are other considerations that investors should not overlook. When it comes to the stock's valuation, the market seems to be overreacting to recent developments that will most likely be transitional in nature.